Alcidion Group

Alcidion Group Net Margin

The Net Profit Margin of Alcidion Group (ALC.AX) as of Nov 11, 2026 is 4.42 %. In the previous year, Net Profit Margin was 4.06 % — a change of 9.11% (higher).

Net Margin

4.42 %

YoY

9.11%

Last updated:

Net Profit Margin of Alcidion Group is 2026 4.42 % . Net Profit Margin of Alcidion Group was 2025 4.06 % . It decreases by 9.11% higher compared to the previous year.

Alcidion Group's net margin stands at 4.4%, up from -12.8% several years earlier.

The Alcidion Group Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
-0.50 AUD
Jan 1, 2020
-16.58 AUD
Jan 1, 2021
-8.67 AUD
Jan 1, 2022
-12.84 AUD
Jan 1, 2023
-8.95 AUD
Jan 1, 2024
-22.71 AUD
Jan 1, 2025
4.06 AUD
Jan 1, 2026
4.42 AUD
The Alcidion Group Net Margin history
YEARNet MarginYoY
4.42 %+9.11%
4.06 %-117.85%
-22.71 %+153.70%
-8.95 %-30.29%
-12.84 %+48.12%
-8.67 %-47.72%
-16.58 %+3,223.03%
-0.50 %-99.00%
-49.99 %-16.12%
-59.60 %-5.73%
-63.22 %+1,076.55%
-5.37 %-14.40%
-6.28 %-42.03%
-10.83 %-62.50%
-28.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alcidion Group Stock analysis

What does Alcidion Group do? Alcidion Group Ltd. generates revenue through the development and licensing of its healthcare software products, including Miya Precision, Miya Observations, Flow, Task Management, and PAS, marketed under the Miya brand. The company also resells selected healthcare software from strategic partners and provides implementation, support, maintenance, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product Miya Precision, a FHIR-event platform-based solution, supports clinical and operational applications, while Smartpage offers hospital communication and task management via smartphone and web. The firm serves over 400 hospitals across its key markets. Miya Precision and its associated modules form the core of Alcidion's product portfolio, targeting hospitals seeking integrated clinical solutions. Smartpage, Patientrack, and Silverlink PCS complement these offerings, catering to diverse healthcare communication and operational needs. The company’s revenue streams are driven by direct sales of software licenses, ongoing service contracts, and partner resales, with a focus on the Australian, New Zealand, and UK healthcare sectors. Alcidion’s business model emphasizes software licensing and service delivery, with Miya Precision as the primary revenue generator. The company’s strategic partnerships enable it to resell third-party software, expanding its product range without additional development costs. Healthcare institutions in Australia, New Zealand, and the United Kingdom are the primary buyers, leveraging Alcidion’s solutions for improved clinical workflows and operational efficiency. Alcidion Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcidion Group stock

Net Profit Margin of Alcidion Group is 4.42 % in 2026.

Net Profit Margin of Alcidion Group changed from 4.06 % to 4.42 %, representing a 9.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Alcidion Group since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Alcidion Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Alcidion Group

All Key Metrics — Alcidion Group